BAYLOR COLLEGE OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1900-10-30
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.bcm.edu
Multiple Myeloma Trial of Orally Administered Salmonella Based Survivin Vaccine
Phase 1
Completed
- Conditions
- Multiple Myeloma
- Interventions
- Biological: CVD908ssb-TXSVN
- First Posted Date
- 2018-12-03
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 1
- Registration Number
- NCT03762291
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
Phase 1
Recruiting
- Conditions
- Head and Neck Squamous Cell CarcinomaCancer of the Salivary GlandPancreatic AdenocarcinomaBladder CancerBreast CancerEsophageal CancerLung CancerGastric CancerColorectal CancerSolid Tumor
- Interventions
- Biological: CAdVEC
- First Posted Date
- 2018-11-14
- Last Posted Date
- 2025-04-22
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 45
- Registration Number
- NCT03740256
- Locations
- 🇺🇸
Baylor St. Luke's Medical Center, Houston, Texas, United States
Chronic Liver Disease in Urea Cycle Disorders
Completed
- Conditions
- Urea Cycle Disorder
- Interventions
- Other: Diagnostic Ultrasound
- First Posted Date
- 2018-10-26
- Last Posted Date
- 2023-02-10
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 28
- Registration Number
- NCT03721367
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Stepped-Care Cognitive-Behavioral Treatment for Youth With ASD and Anxiety
Not Applicable
Completed
- Conditions
- Obsessive-Compulsive DisorderGeneralized Anxiety DisorderCognitive Behavioral TherapySocial Anxiety DisorderAnxiety DisordersSpecific PhobiaAutism Spectrum Disorder
- Interventions
- Behavioral: Stepped Care CBT
- First Posted Date
- 2018-10-25
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 76
- Registration Number
- NCT03720795
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed on Autologous T Cells
Phase 1
Recruiting
- Conditions
- T-non-Hodgkin LymphomaT-cell Acute Lymphoblastic LymphomaT-cell Acute Lymphoblastic Leukemia
- Interventions
- Genetic: CD7.CAR/28zeta CAR T cells
- First Posted Date
- 2018-10-01
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 27
- Registration Number
- NCT03690011
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸Houston Methodist Hospital, Houston, Texas, United States
Cardiac Biomarkers in Patients With Single Ventricle Physiology
Completed
- Conditions
- Cyanotic Congenital Heart DiseaseHypoplastic Left HeartCongenital Heart DiseaseCardiac Disease
- Interventions
- Procedure: Norwood Palliation / DKS / Damus-Kaye-Stansel procedure
- First Posted Date
- 2018-09-20
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 19
- Registration Number
- NCT03678909
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
Tranexamic Acid Per Inhalation for Treatment of Pulmonary Hemorrhage in Pediatric Patients
Completed
- Conditions
- Pulmonary HemorrhageMAPCA - Major Aortopulmonary Collateral Artery
- Interventions
- First Posted Date
- 2018-09-18
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 20
- Registration Number
- NCT03676023
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
VITAL Start: Brief Facility-based Video Intervention
Not Applicable
Completed
- Conditions
- HIV/AIDS
- Interventions
- Behavioral: Standard of Care
- First Posted Date
- 2018-08-31
- Last Posted Date
- 2023-11-24
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 800
- Registration Number
- NCT03654898
- Locations
- 🇲🇼
Baylor-Malawi, Lilongwe, Malawi
C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)
Phase 1
Active, not recruiting
- Conditions
- Relapsed NeuroblastomaUveal MelanomaPhyllodes Breast TumorRefractory NeuroblastomaRelapsed OsteosarcomaRelapsed Ewing SarcomaRelapsed Rhabdomyosarcoma
- Interventions
- Genetic: C7R-GD2.CART cells
- First Posted Date
- 2018-08-17
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 94
- Registration Number
- NCT03635632
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸Texas Children's Hospital, Houston, Texas, United States
Coaching and Education for Diabetes Distress
Not Applicable
Terminated
- Conditions
- Diabetes Distress
- Interventions
- Behavioral: Health coachingOther: Diabetes Distress-specific Education
- First Posted Date
- 2018-08-06
- Last Posted Date
- 2021-01-22
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 19
- Registration Number
- NCT03617146
- Locations
- 🇺🇸
Baylor Family Medicine, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath